Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Giladi, Nir; Alcalay, Roy N.; Cutter, Gary; Gasser, Thomas; Gurevich, Tanya; Hoeglinger, Guenter U.; Marek, Kenneth; Pacchetti, Claudio; Schapira, Anthony H., V; Scherzer, Clemens R.; Simuni, Tanya; Minini, Pascal; Sardi, S. Pablo; Peterschmitt, M. Judith

dc.contributor.author	Gasser, Thomas
dc.date.accessioned	2024-01-11T11:29:18Z
dc.date.available	2024-01-11T11:29:18Z
dc.date.issued	2023
dc.identifier.issn	1474-4422
dc.identifier.uri	http://hdl.handle.net/10900/149155
dc.language.iso	en	en
dc.publisher	New York : Elsevier Science Inc	de_DE
dc.relation.uri	https://doi.org/10.1016/S1474-4422(23)00205-3	de_DE
dc.subject.ddc	610	de_DE
dc.title	Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_00333
utue.publikation.seiten	661-671	de_DE
utue.personen.roh	Giladi, Nir
utue.personen.roh	Alcalay, Roy N.
utue.personen.roh	Cutter, Gary
utue.personen.roh	Gasser, Thomas
utue.personen.roh	Gurevich, Tanya
utue.personen.roh	Hoeglinger, Guenter U.
utue.personen.roh	Marek, Kenneth
utue.personen.roh	Pacchetti, Claudio
utue.personen.roh	Schapira, Anthony H., V
utue.personen.roh	Scherzer, Clemens R.
utue.personen.roh	Simuni, Tanya
utue.personen.roh	Minini, Pascal
utue.personen.roh	Sardi, S. Pablo
utue.personen.roh	Peterschmitt, M. Judith
dcterms.isPartOf.ZSTitelID	Lancet Neurology	de_DE
dcterms.isPartOf.ZS-Issue	8	de_DE
dcterms.isPartOf.ZS-Volume	22	de_DE
utue.fakultaet	Sonstige
utue.fakultaet	04 Medizinische Fakultät